Nanoform small is powerful logo Nanoform small is powerful logo
  • Contact Us
  • About Nanoform
    About Nanoform
    • Vision, mission and values
    • Organization
      Board of Directors
      CEO and Management Team
    • Success stories
    • Corporate Responsibility
  • Technology
    Technology
    • CESS®
      STARMAP®
    • Biologics
      Formulations
    • Case studies
  • Services
    Services
    • GMP Manufacturing
  • Corporate Governance
    Corporate Governance
    • Corporate Governance Statements
      General meeting
      Annual General Meeting 2022
      General meetings
    • The Board of Directors
      Board of Directors
      Duties of the Board of Directors
      Authorisations
      Board committees
      Remuneration of the Board
    • CEO and Management Team
      Remuneration
      Audit
      Internal Control and Risk Management
      Code of conduct
    • Articles of Association
      Insider administration
      Disclosure policy
      Transcations of managers
  • Investors
    Investors Investerare Sijoittajat
    • Financial Reports and Presentations
      Press releases
      Subscribe
    • Share and shareholders
      Share information
      Share capital development
      Certified Adviser
      Analyst Coverage
      Ownership structure
      Notifications of major shareholdings
      Manager Transactions
    • IPO 2020
    • Investor calendar
      Contact
    • Finansiella rapporter och presentationer
      Pressmeddelanden
      Prenumerera
    • Aktien och aktieägare
      Aktieinformation
      Aktiekapitalets utveckling
      Certified Adviser
      Analytiker
      Ägarstruktur
      Anmälan om betydande aktieägare
      Transaktioner utförda av personer i ledande ställning
    • Börsnotering
    • Investerarkalender
      Kontakt
    • Taloudelliset raportit ja esitykset
      Tiedotteet
      Tilaaminen
    • Osake ja osakkeeomistajat
      Tiedot osakkeesta
      Osakepääoman kehitys
      Hyväksytty neuvonantaja
      Analyytikot
      Omistusrakenne
      Ilmoitukset merkittävistä osakkeenomistajista
      Johtohenkilöiden liiketoimet
    • Listautuminen
    • Sijoittajakalenteri
      Yhteystiedot
  • Media
    Media
    • Press releases
      News
    • Pharmaceutical events
      Articles & videos
    • Subscribe
      Brochure
    • Contact
  • Careers
  • Contact

Initial Public Offering of Nanoform on Nasdaq First North Premier Growth Market - June 4th, 2020

IPO materials

  • Company Presentation Video from May 26th Webcast
  • May 25, 2020 - Suomi Nanoform Finland Oyj – Listalleottoesite – May 22, 2020
  • May 25, 2020 - English / Svenska Nanoform Finland Plc – Offering Circular – May 22, 2020
All materials

Press releases

  • Regulatory June 10, 2020
    Exercise of over-allotment option in relation to the initial public offering of Nanoform Finland Plc and termination of the stabilization period
  • Regulatory June 9, 2020
    Nanoform Finland Plc’s ten largest shareholders after the completion of the Initial Public Offering
  • Regulatory June 3, 2020
    The IPO of Nanoform has been considerably oversubscribed and the listing will be completed as planned – trading in the shares is expected to commence tomorrow
All press releases

Contact us

+358 29 370 0150
info@nanoform.com

  • Privacy notice
  • Cookies

Subscribe

Read more about our protection of your personal data.

Nanoform Finland Oyj
Cultivator II, Viikinkaari 4
FI-00790 Helsinki
Finland
Company number: 2730572-8